About Rubius Therapeutics

Rubius Therapeutics, a 2017 “Fierce 15” award winner, is creating Red-Cell Therapeutics™ as an innovative new class of medicines which address a wide array of diseases and disorders. The company’s lead programs include rare disease, cancer, and autoimmune disease. The company was founded by Flagship Pioneering in 2014 and has been capitalized with $240 – more... 

Claimed Profile
Headquarters
325 Vassar Street
Cambridge, MA 02139
Employees
51 to 200
Industry
Links
Rubius Therapeutics website